Novel approaches to female sexual dysfunction

被引:13
|
作者
Berman, LA [1 ]
Berman, JR [1 ]
Chhabra, S [1 ]
Goldstein, I [1 ]
机构
[1] Boston Univ, Med Ctr, Div Urol, Boston, MA 02215 USA
关键词
apomorphine; female pelvic anatomy; female sexual disorders; female sexual dysfunction; L-arginine; methyltestosterone; neurogenic mediators; oestrogen; phentolamine; prostaglandin E1; sildenafil; testosterone; yohimbine;
D O I
10.1517/13543784.10.1.85
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Female sexual dysfunction is age-related, progressive and highly prevalent, affecting 30 - 50% of American women. While there are emotional and relational elements to sexual function, it has become increasingly evident that female sexual dysfunction can occur secondary to medical problems and has an organic basis. A plethora of different female sexual dysfunctions exist and in order to obtain a greater understanding of the possible treatments for these problems, it is essential to have a strong knowledge base of female pelvic anatomy, the neurogenic mediators of female sexual response, the impact of hormones on female sexual function and the aetiologies of female sexual dysfunction. Currently, there are potential therapeutic options for the treatment of female sexual dysfunction and these options include both hormonal and pharmacological therapy. However, therapeutic agents may not prove to be enough and the ideal approach to female sexual dysfunction is thus a collaborative effort between therapists and physicians, which should include a complete medical and psychosocial evaluation, as well as inclusion of the partner or spouse in the evaluation and treatment process.
引用
收藏
页码:85 / 95
页数:11
相关论文
共 50 条
  • [41] Female sexual dysfunction: are urogynecologists ready for it?
    Anne-Marie Roos
    Ranee Thakar
    Abdul H. Sultan
    Inka Scheer
    International Urogynecology Journal, 2009, 20 : 89 - 101
  • [42] Obesity and sexual dysfunction, male and female
    K Esposito
    F Giugliano
    M Ciotola
    M De Sio
    M D'Armiento
    D Giugliano
    International Journal of Impotence Research, 2008, 20 : 358 - 365
  • [43] Physiology of female sexual function and dysfunction
    J R Berman
    International Journal of Impotence Research, 2005, 17 : S44 - S51
  • [44] Psychotherapy in Treating Female Sexual Dysfunction
    Kelley, Erika L.
    Althof, Stanley E.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2025, 68 (01) : 3 - 9
  • [45] Female Sexual Dysfunction, Sexual Distress, and Compatibility with Partner
    Witting, Katarina
    Santtila, Pekka
    Varjonen, Markus
    Jern, Patrick
    Johansson, Ada
    von der Pahlen, Bettina
    Sandnabba, Kenneth
    JOURNAL OF SEXUAL MEDICINE, 2008, 5 (11) : 2587 - 2599
  • [46] Association of resilience with female sexual dysfunction
    Sood, Richa
    Mara, Kristin C.
    Vencill, Jennifer A.
    Kling, Juliana M.
    Faubion, Stephanie S.
    MATURITAS, 2024, 183
  • [47] Psychotherapeutic interventions for female sexual dysfunction
    Bitzer, Johannes
    Brandenburg, Ulrike
    MATURITAS, 2009, 63 (02) : 160 - 163
  • [48] FEMALE SEXUAL DYSFUNCTION AS A CAUSE OF INFERTILITY
    Ohkawa, Reiko
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 334 - 334
  • [49] Female sexual dysfunction: are urogynecologists ready for it?
    Roos, Anne-Marie
    Thakar, Ranee
    Sultan, Abdul H.
    Scheer, Inka
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2009, 20 (01) : 89 - 101
  • [50] Phosphodiesterase inhibitors in female sexual dysfunction
    Mayer, M
    Stief, CG
    Truss, MC
    Ückert, S
    WORLD JOURNAL OF UROLOGY, 2005, 23 (06) : 393 - 397